Procalcitonin has a poor prognosis value in critically ill patients with candidemia

por Charles, PE, Bruyère, R, Roche, H, Quenot, JP, Prin, S, Pavon, A, Dalle, F
Publicado 2012

Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure

por Bonneterre, J, Roché, H, Monnier, A, Guastalla, J P, Namer, M, Fargeot, P, Assadourian, S
Publicado 2002

Clinical pharmacodynamic factors in docetaxel toxicity

por Puisset, F, Alexandre, J, Treluyer, J-M, Raoul, V, Roché, H, Goldwasser, F, Chatelut, E
Publicado 2007

Potential prognostic value in human breast cancer of cytosolic Nme1 protein detection using an original hen specific antibody.

por Toulas, C., Mihura, J., de Balincourt, C., Marques, B., Marek, E., Soula, G., Roche, H., Favre, G.
Publicado 1996

Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamil.

por Julia, A. M., Roché, H., Berlion, M., Lucas, C., Milano, G., Robert, J., Bizzari, J. P., Canal, P.
Publicado 1994

Design of RESILIENCE: a phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer

por Baselga, J, Costa, F, Gomez, H, Hudis, C, Rapoport, B, Roche, H, Schwartzberg, LS, Petrenciuc, O, Shan, M, Gradishar, WJ
Publicado 2011

Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer

por Vasey, P A, Roché, H, Bisset, D, Terret, C, Vernillet, L, Riva, A, Ramazeilles, C, Azli, N, Kaye, S B, Twelves, C J
Publicado 2002

Identification of a plasma signature of psychotic disorder in children and adolescents from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort

por O'Gorman, A, Suvitaival, T, Ahonen, L, Cannon, M, Zammit, S, Lewis, G, Roche, H M, Mattila, I, Hyotylainen, T, Oresic, M, Brennan, L, Cotter, D R
Publicado 2017

A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. Europe...

por Dieras, V., Chevallier, B., Kerbrat, P., Krakowski, I., Roche, H., Misset, J. L., Lentz, M. A., Azli, N., Murawsky, M., Riva, A., Pouillart, P., Fumoleau, P.
Publicado 1996

Participants’ uptake of clinical trial results: a randomised experiment

por Mancini, J, Genre, D, Dalenc, F, Ferrero, J-M, Kerbrat, P, Martin, A-L, Roché, H, Maylevin, F, Tarpin, C, Viens, P, Genève, J, Julian-Reynier, C
Publicado 2010

High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer

por Brain, E, Levy, C, Serin, D, Roché, H, Spielmann, M, Delva, R, Veyret, C, Mauriac, L, Rios, M, Martin, A L, Jimenez, M, Asselain, B, Gauthier, M, Bonnetain, F, Fumoleau, P
Publicado 2011

Choosing a career in oncology: results of a nationwide cross-sectional study

por Faivre, J. C., Bibault, J. E., Bellesoeur, A., Salleron, J., Wack, M., Biau, J., Cervellera, M., Janoray, G., Leroy, T., Lescut, N., Martin, V., Molina, S., Pichon, B., Teyssier, C., Thureau, S., Mazeron, J. J., Roché, H., Culine, S.
Publicado 2018

Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?

por Bouffet, E., Doz, F., Demaille, M. C., Tron, P., Roche, H., Plantaz, D., Thyss, A., Stephan, J. L., Lejars, O., Sariban, E., Buclon, M., Zücker, J. M., Brunat-Mentigny, M., Bernard, J. L., Gentet, J. C.
Publicado 1998

Epirubicin–vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial

por Kerbrat, P, Roché, H, Bonneterre, J, Veyret, C, Lortholary, A, Monnier, A, Fumoleau, P, Fargeot, P, Namer, M, Chollet, P, Goudier, M-J, Audhuy, B, Simon, H, Montcuquet, P, Eymard, J-C, Walter, S, Clavère, P, Guastalla, J-P
Publicado 2007

First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 tria...

por Viens, P, Palangié, T, Janvier, M, Fabbro, M, Roché, H, Delozier, T, Labat, J P, Linassier, C, Audhuy, B, Feuilhade, F, Costa, B, Delva, R, Cure, H, Rousseau, F, Guillot, A, Mousseau, M, Ferrero, J M, Bardou, V J, Jacquemier, J, Pouillart, P
Publicado 1999